Can a single pill reveal the Brain's role in alcoholism risk?
NCT ID NCT05203965
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 21 times
Summary
This study aims to understand why some people are more vulnerable to alcoholism by looking at brain activity. Researchers will give 80 adults with a family history of alcohol problems either a single dose of the drug mavoglurant or a placebo, then use MRI scans to see how their brains respond to rewards and alcohol-related images. The goal is to learn more about the brain chemistry behind addiction risk, not to treat or cure alcoholism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAMILIAL ALCOHOLISM VULNERABILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hartford Hospital
RECRUITINGHartford, Connecticut, 06106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.